Cell cycle-based therapies move forward
- PMID: 23079651
- DOI: 10.1016/j.ccr.2012.09.024
Cell cycle-based therapies move forward
Abstract
Targeted therapies directed against cell cycle regulators have been difficult to translate into the clinic. In this issue of Cancer Cell, Choi et al. and Sawai et al. rekindle the therapeutic value of inhibiting specific cyclin-dependent kinase complexes by demonstrating their requirements in the maintenance of breast tumors and leukemias.
Copyright © 2012 Elsevier Inc. All rights reserved.
Comment on
-
The requirement for cyclin D function in tumor maintenance.Cancer Cell. 2012 Oct 16;22(4):438-51. doi: 10.1016/j.ccr.2012.09.015. Cancer Cell. 2012. PMID: 23079655 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
